ATE454149T1 - Halogenierte chindolin-dimere zur behandlung von krebs - Google Patents

Halogenierte chindolin-dimere zur behandlung von krebs

Info

Publication number
ATE454149T1
ATE454149T1 AT06763131T AT06763131T ATE454149T1 AT E454149 T1 ATE454149 T1 AT E454149T1 AT 06763131 T AT06763131 T AT 06763131T AT 06763131 T AT06763131 T AT 06763131T AT E454149 T1 ATE454149 T1 AT E454149T1
Authority
AT
Austria
Prior art keywords
quindoline
dimers
cancer
halogenated
treatment
Prior art date
Application number
AT06763131T
Other languages
English (en)
Inventor
Bofarull Juan Aymamoe
Munoz Isabel Navarro
Original Assignee
Crystax Pharmaceuticals S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crystax Pharmaceuticals S L filed Critical Crystax Pharmaceuticals S L
Application granted granted Critical
Publication of ATE454149T1 publication Critical patent/ATE454149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT06763131T 2005-05-20 2006-05-12 Halogenierte chindolin-dimere zur behandlung von krebs ATE454149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005023978 2005-05-20
PCT/EP2006/062277 WO2006122910A1 (en) 2005-05-20 2006-05-12 Halogenated quindoline dimers for the treatment of cancer

Publications (1)

Publication Number Publication Date
ATE454149T1 true ATE454149T1 (de) 2010-01-15

Family

ID=36702655

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06763131T ATE454149T1 (de) 2005-05-20 2006-05-12 Halogenierte chindolin-dimere zur behandlung von krebs

Country Status (5)

Country Link
EP (1) EP1885364B1 (de)
AT (1) ATE454149T1 (de)
DE (1) DE602006011603D1 (de)
ES (1) ES2339152T3 (de)
WO (1) WO2006122910A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2014698A1 (de) * 2007-07-12 2009-01-14 Crystax Pharmaceuticals S.L. Polymere und ihre Verwendung als Fluoreszenzmarker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998045272A1 (en) * 1997-04-07 1998-10-15 Latrobe University Topoisomerase inhibitors
US7728000B2 (en) * 2003-11-20 2010-06-01 Crystax Pharmaceuticals Substituted quinolines for the treatment of cancer

Also Published As

Publication number Publication date
DE602006011603D1 (de) 2010-02-25
ES2339152T3 (es) 2010-05-17
WO2006122910A1 (en) 2006-11-23
EP1885364B1 (de) 2010-01-06
EP1885364A1 (de) 2008-02-13

Similar Documents

Publication Publication Date Title
DK1853602T3 (da) Kemiske forbindelser
CY1108275T1 (el) Χημικες ενωσεις
EA201690265A3 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200900798A1 (ru) Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
UA107783C2 (en) Isoindoline compounds for use in treating cancer
BRPI0514017A (pt) indazóis úteis no tratamento de doenças cardiovasculares
CY1110108T1 (el) Παραγωγα ισοκινολινης ως αναστολεις της rho-κινασης
EA200802213A1 (ru) Способы лечения заболеваний крови
EA201000895A1 (ru) Композиции и способы для лечения лизосомных болезней
DK1450799T3 (da) Arylurinstofforbindelser sammen med andre cytostatiske eller cytotoksiske midler til behandling af humane cancere
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
EA201170531A1 (ru) Соединения на основе пиридина и пиримидина в качестве ингибиторов сигнального пути wnt для лечения рака
ECSP088749A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
BRPI0509660A (pt) compostos de beta-carbolina de utilidade no tratamento de doenças inflamatórias
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
DE602006011603D1 (de) Halogenierte chindolin-dimere zur behandlung von krebs
UY29631A1 (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica
ATE491450T1 (de) Behandlung proliferativer erkrankungen mit epothilon-derivaten und bestrahlung
CY1114207T1 (el) Παραγωγα βενζοφουρανυλιου για χρηση ως αναστολεις γλυκοκινασης

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties